UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma

Current oncology (Toronto), 2019-04, Vol.26 (2), p.e233-240

2019

Volltextzugriff (PDF)

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

Annals of oncology, 1998-09, Vol.9 (9), p.995-1001

1998

Volltextzugriff (PDF)

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Annals of oncology, 2017-03, Vol.28 (3), p.622-627

2017

Volltextzugriff (PDF)

Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)

Hematological oncology, 2023-06, Vol.41 (S2), p.396-397

2023

Volltextzugriff (PDF)

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis

Annals of oncology, 2004-02, Vol.15 (2), p.283-290

2004

Volltextzugriff (PDF)

Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer

Annals of oncology, 2013-10, Vol.24 (10), p.2534-2542

2013

Volltextzugriff (PDF)

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

Bone marrow transplantation (Basingstoke), 2009-05, Vol.43 (9), p.701-708

2009

Volltextzugriff (PDF)

In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node

Leukemia, 2009-06, Vol.23 (6), p.1176-1179

2009

Volltextzugriff (PDF)

Overview of therapeutic vaccination approaches for cancer

Seminars in oncology, 2003-06, Vol.30 (3 Suppl 8), p.1-8

Berinstein, Neil

2003

Volltextzugriff (PDF)

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab

Annals of hematology, 2015-05, Vol.94 (5), p.813-823

2015

Volltextzugriff (PDF)

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as ‘in vivo purge’ and consolidative immunotherapy following autologous stem cell transplantation

Annals of oncology, 2003-05, Vol.14 (5), p.758-765

2003

Volltextzugriff (PDF)

What is remission in follicular lymphoma and what is its relevance?

Best practice & research. Clinical haematology, 2005-03, Vol.18 (1), p.27-56

2005

Volltextzugriff (PDF)

Stem cell function and engraftment is not affected by in vivo purging with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma

Seminars in oncology, 1999-10, Vol.26 (5), p.115-122

1999

Volltextzugriff (PDF)

Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines

The Journal of immunology (1950), 1997-05, Vol.158 (10), p.4591-4601

1997

Volltextzugriff (PDF)

4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine

The Journal of immunology (1950), 1999-04, Vol.162 (8), p.5003-5010

1999

Volltextzugriff (PDF)

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS

Leukemia research, 2023-05, Vol.128, p.107239, Article 107239

2023

Volltextzugriff (PDF)

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

Journal of clinical oncology, 1994-05, Vol.12 (5), p.1074-1084

1994

Volltextzugriff (PDF)

Molecular diagnostics in follicular non-Hodgkin's lymphoma : A review

Seminars in oncology, 2000-12, Vol.27 (6), p.42-52

2000

Volltextzugriff (PDF)

Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma

Journal of clinical oncology, 1993-07, Vol.11 (7), p.1344-1352

1993

Volltextzugriff (PDF)

Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2002-02, Vol.29 Suppl 1 (S1), p.S14-S17

2002

Volltextzugriff (PDF)

Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature

Neuro-oncology (Charlottesville, Va.), 2000-10, Vol.2 (4), p.239-243

2000

Volltextzugriff (PDF)

SPIReL: PHASE 2 STUDY DPX‐SURVIVAC WITH INTERMITTENT LOW DOSE CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.569-569

2019

Volltextzugriff (PDF)

Cytomegalovirus retinitis and low‐grade non‐Hodgkin's lymphoma: Case report and review of the literature

American journal of hematology, 1998-03, Vol.57 (3), p.228-232

1998

Volltextzugriff (PDF)

Therapeutic vaccines and cancer : focus on DPX-0907

Biologics, 2014-01, Vol.8 (default), p.27-38

2014

Volltextzugriff (PDF)

Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector

Human gene therapy, 2000-06, Vol.11 (9), p.1289-1301

2000

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(102)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(103)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma

Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial

Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)

Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis

Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer

Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node

Overview of therapeutic vaccination approaches for cancer

Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab

Pharmacokinetic study of patients with follicular or mantle cell lymphoma treated with rituximab as ‘in vivo purge’ and consolidative immunotherapy following autologous stem cell transplantation

What is remission in follicular lymphoma and what is its relevance?

Stem cell function and engraftment is not affected by in vivo purging with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma

Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines

4-1BBL Cooperates with B7-1 and B7-2 in Converting a B Cell Lymphoma Cell Line into a Long-Lasting Antitumor Vaccine

Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS

Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review

Molecular diagnostics in follicular non-Hodgkin's lymphoma : A review

Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma

Bcl-2 clearance: optimising outcomes in follicular non-Hodgkin's lymphoma

Primary Hodgkin's disease of the CNS in an immunocompetent patient: a case study and review of the literature

SPIReL: PHASE 2 STUDY DPX‐SURVIVAC WITH INTERMITTENT LOW DOSE CYCLOPHOSPHAMIDE AND PEMBROLIZUMAB IN PATIENTS WITH RECURRENT/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA

Cytomegalovirus retinitis and low‐grade non‐Hodgkin's lymphoma: Case report and review of the literature

Therapeutic vaccines and cancer : focus on DPX-0907

Immunogenicity of whole-cell tumor preparations infected with the ALVAC viral vector

Suchergebnisse filtern